21st Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)

Sussex Research Laboratories Inc. is excited to be participating at the 21st Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) (OTS), taking place in Budapest, Hungary, from October 19–22, 2025.

Oligonucleotide-based therapeutics continue to transform the landscape of modern medicine, with significant advances in molecular targeting, delivery technologies and clinical applications across a broad spectrum of diseases.

The #OTS Annual Meeting brings together leading scientists at the forefront of oligonucleotide research. This gathering serves as a premier forum for sharing cutting-edge science, fostering collaborations and shaping the future of nucleic acid therapeutics. The growing complexity of these therapies and delivery systems underscores the critical need for innovative targeted delivery.

We invite you to visit Booth #12, where Brady Clark (CEO) and Remmick So (COO) will be available to discuss how Sussex Research, a recognized leader & CRO in custom glycan synthesis, can support and differentiate your oligonucleotide therapeutic programs. Our specialized expertise in glycan-based delivery strategies, including hepatic and extra-hepatic targeting, offers a powerful approach to enhancing specificity and efficacy.

We look forward to connecting in Budapest to explore how we can empower your therapeutic innovation through glycoscience.